#$%^&*AU2017213440A120170824.pdf#####Abstract The present invention features methods for treating or ameliorating tissue damage using intravenous administration of compositions that include stromal cell derived factor-I (SDF-1) peptides or mutant SDF-1 peptides that have been mutated to make them resistant to protease digestion, but which retain chemoattractant activity.